Shares of Preveceutical Medical Inc (CNSX:PREV) traded down 20% during trading on Friday . The company traded as low as $0.04 and last traded at $0.04, 275,509 shares were traded during trading. The stock had previously closed at $0.05.
The business has a 50-day simple moving average of $0.05.
About Preveceutical Medical (CNSX:PREV)
PreveCeutical Medical Inc, a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions.
Featured Story: Diversification For Individual Investors
Receive News & Ratings for Preveceutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Preveceutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.